Astragalus polysaccharides can reduce CA125 levels and VEGF expression in NSCLC patients, and when used concurrently with radiotherapy, they can decrease the incidence of bone marrow suppression.79 The gene discussed is VEGFA; the disease is non-small cell lung carcinoma.